Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
258.65
+4.96 (1.96%)
At close: Mar 9, 2026, 4:00 PM EDT
263.82
+5.17 (2.00%)
After-hours: Mar 9, 2026, 4:53 PM EDT
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $7.56 billion as of March 9, 2026. Its market cap has increased by 43.73% in one year.
Market Cap
7.56B
Enterprise Value
6.61B
1-Year Change
43.73%
Ranking
Category
Stock Price
$258.65
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $7.56B, an increase of 8,082.80%. That is a compound annual growth rate of 68.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.42B | 3.73% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Praxis Precision Medicines | 8.58B |
| Vaxcyte | 8.53B |
| Arrowhead Pharmaceuticals | 8.50B |
| ABIVAX Société Anonyme | 8.49B |
| Axsome Therapeutics | 8.41B |
| Nuvalent | 8.04B |
| Halozyme Therapeutics | 8.03B |
| Cytokinetics | 7.69B |